4.7 Article

Acute Otitis Media Replacement and Recurrence in the Finnish Otitis Media Vaccine Trial

Journal

CLINICAL INFECTIOUS DISEASES
Volume 55, Issue 12, Pages 1673-1676

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/cis799

Keywords

-

Funding

  1. GlaxoSmithKline
  2. SanofiPasteur MSD
  3. Merck
  4. Pasteur Merieux Connaught
  5. Wyeth Lederle Vaccines and Pediatrics

Ask authors/readers for more resources

We reanalyzed the 7-valent pneumococcal conjugate vaccine trial FinOM for prevention of acute otitis media (AOM), with a focus on disease replacement due to other pathogens and AOM recurrence. We found evidence of replacement disease occurring early during the trial follow-up and little vaccine impact on recurrent overall AOM episodes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available